Systemic sclerosis and the gastrointestinal tract

Irena Walecka

doi:10.5114/pg.2017.70467

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2017
vol. 12

Send email

Copy url:

abstract:

Review paper

Systemic sclerosis and the gastrointestinal tract

Irena Walecka

Gastroenterology Rev 2017; 12 (3): 163–168

DOI: https://doi.org/10.5114/pg.2017.70467

Online publish date: 2017/09/30

View full text Get citation

PlumX metrics:

Systemic sclerosis (SSc) is an autoimmunological disease of unknown origin with complex pathogenesis and multiple organ involvement. It is characterised by vascular and immunological abnormalities leading to fibrosis of the skin and internal organs. It is a rather rare disease with a prevalence of around 20 per 100,000. The disease results in heterogeneous clinical findings and different courses. Systemic sclerosis usually begins with the onset of Raynaud’s phenomenon (RP), followed by skin sclerosis and internal organ involvement, although it may appear synchronously with RP. Gastrointestinal involvement is a serious and prevalent complication of SSc, and the oesophagus is the most frequently affected organ. Both limited and diffuse cutaneous SSc involve internal organs, with the involvement of the gastrointestinal tract as a leading cause of morbidity. At present, treatment is mainly symptomatic with no disease-modifying drugs.

keywords:

Systemic sclerosis and the gastrointestinal tract

Irena Walecka

systemic sclerosis, gastrointestinal involvement, autoantibodies